184 related articles for article (PubMed ID: 31896809)
1. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
Pareja F; da Silva EM; Frosina D; Geyer FC; Lozada JR; Basili T; Da Cruz Paula A; Zhong E; Derakhshan F; D'Alfonso T; Wen HY; Giri DD; Hayes MM; Krings G; Bhargava R; Palazzo JP; Rakha EA; Hoda SA; Sanders ME; Collins LC; Schnitt SJ; Chen YY; Weigelt B; Jungbluth AA; Reis-Filho JS; Brogi E
Mod Pathol; 2020 Jun; 33(6):1056-1064. PubMed ID: 31896809
[TBL] [Abstract][Full Text] [Related]
2. Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
Lozada JR; Basili T; Pareja F; Alemar B; Paula ADC; Gularte-Merida R; Giri DD; Querzoli P; Cserni G; Rakha EA; Foschini MP; Reis-Filho JS; Brogi E; Weigelt B; Geyer FC
Histopathology; 2018 Aug; 73(2):339-344. PubMed ID: 29603332
[TBL] [Abstract][Full Text] [Related]
3. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Utility of IDH2 R172 Immunohistochemistry in Tall Cell Carcinoma With Reversed Polarity of the Breast.
Sasaki E; Iwakoshi A; Satake T; Nakajima K; Kobayashi M; Ando Y; Koshikawa T; Masago K; Honma N; Nishimura R; Kato Y; Ichihara S
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):654-661. PubMed ID: 36222504
[TBL] [Abstract][Full Text] [Related]
5. Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid Carcinoma: Molecular Characterization by Next-Generation Sequencing and Histopathological Comparison With Tall Cell Papillary Carcinoma of Thyroid.
Zhong E; Scognamiglio T; D'Alfonso T; Song W; Tran H; Baek I; Hoda SA
Int J Surg Pathol; 2019 Apr; 27(2):134-141. PubMed ID: 30227763
[TBL] [Abstract][Full Text] [Related]
6. IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.
Chiang S; Weigelt B; Wen HC; Pareja F; Raghavendra A; Martelotto LG; Burke KA; Basili T; Li A; Geyer FC; Piscuoglio S; Ng CK; Jungbluth AA; Balss J; Pusch S; Baker GM; Cole KS; von Deimling A; Batten JM; Marotti JD; Soh HC; McCalip BL; Serrano J; Lim RS; Siziopikou KP; Lu S; Liu X; Hammour T; Brogi E; Snuderl M; Iafrate AJ; Reis-Filho JS; Schnitt SJ
Cancer Res; 2016 Dec; 76(24):7118-7129. PubMed ID: 27913435
[TBL] [Abstract][Full Text] [Related]
7. Tall Cell Carcinoma with Reverse Polarity of Breast: Report of a Case with Unique Morphologic and Molecular Features.
Jassim M; Premalata CS; Okaly G; Srinivas C
Turk Patoloji Derg; 2021; 37(2):183-188. PubMed ID: 33021737
[TBL] [Abstract][Full Text] [Related]
8. The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma.
Dogan S; Frosina D; Fayad M; de Oliveira TB; Alemar B; Rosenblum M; Tang LH; Hameed M; Xu B; Ghossein RA; Chute DJ; Weigelt B; Jungbluth AA
Mod Pathol; 2019 Feb; 32(2):205-215. PubMed ID: 30206411
[TBL] [Abstract][Full Text] [Related]
9. Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report.
Haefliger S; Muenst S; Went P; Bihl M; Dellas S; Weber WP; Vlajnic T
Mol Biol Rep; 2020 Jun; 47(6):4917-4921. PubMed ID: 32474846
[TBL] [Abstract][Full Text] [Related]
10. Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review.
Zhang X; Wu H; Wang Z; Zhou Y; Mao F; Lin Y; Shen S; Liang Z; Sun Q
Gland Surg; 2021 Feb; 10(2):837-843. PubMed ID: 33708566
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants.
Dogan S; Frosina D; Geronimo JA; Hernandez E; Mohanty A; Bale T; Hechtman JF; Arcila ME; Hameed MR; Jungbluth AA
Hum Pathol; 2020 Dec; 106():45-53. PubMed ID: 33017591
[TBL] [Abstract][Full Text] [Related]
12. Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations.
Bhargava R; Florea AV; Pelmus M; Jones MW; Bonaventura M; Wald A; Nikiforova M
Am J Clin Pathol; 2017 Apr; 147(4):399-410. PubMed ID: 28375433
[TBL] [Abstract][Full Text] [Related]
13. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas.
Mito JK; Bishop JA; Sadow PM; Stelow EB; Faquin WC; Mills SE; Krane JF; French CA; Fletcher CDM; Hornick JL; Sholl LM; Jo VY
Am J Surg Pathol; 2018 Aug; 42(8):1067-1075. PubMed ID: 29683816
[TBL] [Abstract][Full Text] [Related]
15. Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the Breast: A Case Report.
Shinomiya Y; Kouchi Y; Onodera K; Yamamoto H; Harada-Kagitani S; Sakakibara J; Nagashima T; Ikeda JI; Kishimoto T
Acta Cytol; 2024; 68(1):73-79. PubMed ID: 38262369
[TBL] [Abstract][Full Text] [Related]
16. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
[TBL] [Abstract][Full Text] [Related]
17. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.
Jo VY; Chau NG; Hornick JL; Krane JF; Sholl LM
Mod Pathol; 2017 May; 30(5):650-659. PubMed ID: 28084339
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
[TBL] [Abstract][Full Text] [Related]
20. IDH2 -Mutated Sinonasal Tumors: A Review.
Alzumaili B; Sadow PM
Adv Anat Pathol; 2023 Mar; 30(2):104-111. PubMed ID: 36537260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
